David Wholley assumed his current position as Executive Vice-President and Chief Strategy and Business Development Officer of the Foundation for the National Institutes of Health in May 2022. He served as the Interim President and Executive Director of the Foundation from September 2021 until May 2022, while the organization transitioned to new leadership. Before that, David managed the Research Partnerships Division of the Foundation, where he was responsible for launching major research collaborations including the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the Accelerating Medicines Partnership® Program (AMP®), the Biomarkers Consortium, the LungMAP precision medicine trial in lung cancer, and the Partnership for Advancing Cancer Therapies. Prior to joining FNIH in 2006, David’s career spanned nearly 25 years in healthcare technology business management, including extensive experience in product development, sales, marketing, corporate strategy, and partnership and project development. Mr. Wholley has held senior management roles in several venture-funded technology startup companies, including head of Global Marketing and Development for First Genetic Trust, Inc., which developed software for large-scale collaborative genetic research and personalized medicine. During a 16-year career at IBM, he co-led the corporate strategy team that guided IBM’s formation of its Life Sciences industry organization. Mr. Wholley holds an M.Phil. from Rutgers University and a Certificate in Business Administration from the Stern School of Business at New York University.